Review decisions
Showing 150 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732557043374
Product Type: Drug
Control Number: 259869
DIN(s): 02404508, 02420201
Manufacturer: Biogen Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-22
Decision / Authorization Date: 2023-05-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1711550170651
Product Type: Drug
Control Number: 257284
DIN(s): 02495155, 02520893, 02539721
Manufacturer: AbbVie corp.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-10-05
Decision / Authorization Date: 2023-07-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1709049767533
Product Type: Drug
Control Number: 251521
DIN(s): 02324032, 02371081
Manufacturer: Merz Pharmaceuticals GmbH
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-04-08
Decision / Authorization Date: 2022-03-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1709215072174
Product Type: Drug
Control Number: 273184
DIN(s): 02525267, 02525275
Manufacturer: UCB Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-09
Decision / Authorization Date: 2024-02-23
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1709310383688
Product Type: Drug
Control Number: 261864
DIN(s): 02491559
Manufacturer: Alexion Pharma Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-02-25
Decision / Authorization Date: 2023-01-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708530494939
Product Type: Drug
Control Number: 272504
DIN(s): 02446626, 02446634
Manufacturer: Bristol-Myers Squibb Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-02-15
Decision / Authorization Date: 2023-12-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708630999500
Product Type: Drug
Control Number: 272981
DIN(s): 02511576, 02511584
Manufacturer: Celltrion Healthcare Co., Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-02
Decision / Authorization Date: 2024-02-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708454547343
Product Type: Drug
Control Number: 275152
DIN(s): 02459787, 02459795, 02545136, 02545144, 02545152, 02545160
Manufacturer: Novartis Pharmaceuticals Canada Inc
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-05-10
Decision / Authorization Date: 2024-02-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708464933703
Product Type: Drug
Control Number: 273166
DIN(s): 01981501, 02531577, 02531585
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-10
Decision / Authorization Date: 2024-02-07
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708462789662
Product Type: Drug
Control Number: 266553
DIN(s): 02544334, 02544342
Manufacturer: B. Braun Medical Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-08-22
Decision / Authorization Date: 2024-01-04